Analyst Recommendations
BMO Capital analyst issues OUTPERFORM recommendation for ENOV on July 8, 2026 08:15PM ET. ENOV was trading at $23.63 at issue of the analyst recommendation.The overall analyst consensus...July 8, 2026 ENOV 4.66%
Jefferies analyst issues HOLD recommendation for PMCUF on July 8, 2026 08:14PM ET. The previous analyst recommendation was Buy.PMCUF was trading at $145 at issue of the analyst...July 8, 2026 PMCUF 2.84%
Wolfe Research analyst issues OUTPERFORM recommendation for AMT on July 8, 2026 08:13PM ET. AMT was trading at $165.04 at issue of the analyst recommendation.The overall analyst consensus...July 8, 2026 AMT -0.53%
Evercore ISI analyst issues OUTPERFORM recommendation for BE on July 8, 2026 08:24PM ET. The previous analyst recommendation was Outperform.BE was trading at $254.29 at issue of the...July 8, 2026 BE 1.50%
Barclays analyst issues UNDERWEIGHT recommendation for BE on July 8, 2026 08:24PM ET. BE was trading at $254.29 at issue of the analyst recommendation.The overall analyst consensus :...July 8, 2026 BE 1.50%
Raymond James analyst issues NEUTRAL recommendation for BE on July 8, 2026 08:24PM ET. The previous analyst recommendation was Strong Buy.BE was trading at $254.29 at issue of...July 8, 2026 BE 1.50%
Goldman Sachs analyst issues NEUTRAL recommendation for BE on July 8, 2026 08:24PM ET. BE was trading at $254.29 at issue of the analyst recommendation.The overall analyst consensus...July 8, 2026 BE 1.50%
BMO Capital analyst issues MARKET PERFORM recommendation for XRAY on July 8, 2026 08:23PM ET. XRAY was trading at $11.78 at issue of the analyst recommendation.The overall analyst...July 8, 2026 XRAY 1.74%
BMO Capital analyst issues OUTPERFORM recommendation for ISRG on July 8, 2026 08:19PM ET. ISRG was trading at $415.1 at issue of the analyst recommendation.The overall analyst consensus...July 8, 2026 ISRG -0.78%
BMO Capital analyst issues OUTPERFORM recommendation for GMED on July 8, 2026 08:17PM ET. GMED was trading at $76.2 at issue of the analyst recommendation.The overall analyst consensus...July 8, 2026 GMED 1.38%